Juhan-Vague I - Search Results

1

PAI-1, obesity, insulin resistance and risk of cardiovascular events.

Juhan-Vague I, Alessi MC. Juhan-Vague I, et al. Thromb Haemost. 1997 Jul;78(1):656-60. Thromb Haemost. 1997. PMID: 9198234 Review.

2

Stromal cells are the main plasminogen activator inhibitor-1-producing cells in human fat: evidence of differences between visceral and subcutaneous deposits.

Bastelica D, Morange P, Berthet B, Borghi H, Lacroix O, Grino M, Juhan-Vague I, Alessi MC. Bastelica D, et al. Arterioscler Thromb Vasc Biol. 2002 Jan;22(1):173-8. doi: 10.1161/hq0102.101552. Arterioscler Thromb Vasc Biol. 2002. PMID: 11788479

3

Relationships between fibrinolytic and inflammatory parameters in human adipose tissue: strong contribution of TNFalpha receptors to PAI-1 levels.

Bastelica D, Mavri A, Verdierl M, Berthet B, Juhan-Vague I, Alessi MC. Bastelica D, et al. Thromb Haemost. 2002 Sep;88(3):481-7. Thromb Haemost. 2002. PMID: 12353079

4

Association between TAFI antigen and Ala147Thr polymorphism of the TAFI gene and the angina pectoris incidence. The PRIME Study (Prospective Epidemiological Study of MI).

Morange PE, Juhan-Vague I, Scarabin PY, Alessi MC, Luc G, Arveiler D, Ferrieres J, Amouyel P, Evans A, Ducimetiere P; PRIME Study group. Morange PE, et al. Thromb Haemost. 2003 Mar;89(3):554-60. Thromb Haemost. 2003. PMID: 12624641

5

Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation.

Alessi MC, Bastelica D, Mavri A, Morange P, Berthet B, Grino M, Juhan-Vague I. Alessi MC, et al. Arterioscler Thromb Vasc Biol. 2003 Jul 1;23(7):1262-8. doi: 10.1161/01.ATV.0000077401.36885.BB. Epub 2003 May 15. Arterioscler Thromb Vasc Biol. 2003. PMID: 12750120

6

The insulin resistance syndrome: implications for thrombosis and cardiovascular disease.

Juhan-Vague I, Morange PE, Alessi MC. Juhan-Vague I, et al. Pathophysiol Haemost Thromb. 2002 Sep-Dec;32(5-6):269-73. doi: 10.1159/000073579. Pathophysiol Haemost Thromb. 2002. PMID: 13679655 Review.

7

PPARalpha deficiency does not modify age dependency but prevents high fat diet increase in plasma PAI-1 as well as insulin resistance.

Mavri A, Bastelica D, Staels B, El Ayachi S, Juhan-Vague I, Alessi MC. Mavri A, et al. Thromb Haemost. 2004 May;91(5):1051-2. Thromb Haemost. 2004. PMID: 15116271 No abstract available.

8

Adipose tissue and atherothrombosis.

Alessi MC, Lijnen HR, Bastelica D, Juhan-Vague I. Alessi MC, et al. Pathophysiol Haemost Thromb. 2003 Sep-2004 Dec;33(5-6):290-7. doi: 10.1159/000083816. Pathophysiol Haemost Thromb. 2003. PMID: 15692231 Review.

9

Quantification of thrombin activatable fibrinolysis inhibitor (TAFI) gene polymorphism effects on plasma levels of TAFI measured with assays insensitive to isoform-dependent artefact.

Frère C, Morange PE, Saut N, Tregouet DA, Grosley M, Beltran J, Juhan-Vague I, Alessi MC. Frère C, et al. Thromb Haemost. 2005 Aug;94(2):373-9. doi: 10.1160/TH04-08-0497. Thromb Haemost. 2005. PMID: 16113828

10

PAI-1 and the metabolic syndrome: links, causes, and consequences.

Alessi MC, Juhan-Vague I. Alessi MC, et al. Arterioscler Thromb Vasc Biol. 2006 Oct;26(10):2200-7. doi: 10.1161/01.ATV.0000242905.41404.68. Epub 2006 Aug 24. Arterioscler Thromb Vasc Biol. 2006. PMID: 16931789 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

283 results

Search Page

Filters